Banner - NPPA Connect
Opinion|Videos|August 16, 2024

Navigating the Treatment Paradigm for Vitiligo: Efficacy, MOA, and Long-Term Use of FDA-Approved Topical Ruxolitinib

Ted Lain, MD, MBA, FAAD discusses navigating the treatment paradigm for vitiligo.


Latest CME